Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Urol Oncol. 2022 Dec 30;41(3):149.e11–149.e16. doi: 10.1016/j.urolonc.2022.09.019

Table 1.

Clinical, demographic, and laboratory parameters of patients with oncocytomas managed with active surveillance vs. PN.

PN (n=82) Active Surveillance (n=32) p
N/Median %/IQR N/Median %/IQR
Age (years) 65 59–71 72 64–76 <0.001
Max Tumor Diameter (cm) 2.8 2.5–3.3 2.9 2.6–3.4 0.634
Baseline Cr 0.9 0.8–1.0 1 0.9–1.3 0.0154
Baseline eGFR 82 73–94 71 43–84 <0.001
BMI 28 25–33 29 26–34 0.621
Gender 0.51
 Female 23 28% 11 34%
 Male 59 72% 21 66%
Race 1.00
 White 77 94% 31 97%
 Non-white 5 6.1% 1 3.10%
Hypertension 0.13
 No 30 37% 7 22%
 Yes 52 63% 25 78%